Interestingly, Donepezil, an acetylcholinesterase inhibitor used in AD, was shown to inhibit Kv2.1 with an IC50 value of 7.6 μM and may thus add protection against neuronal cell death (Yuan et al., 2011). This evidence concerns the gene KCNB1 and Alzheimer disease.